ClinicalTrials.Veeva

Menu

Efficacy of Conservative Treatment of Functional Defecatory Disorders in Females With Pelvic Organ Prolapse

F

Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology

Status and phase

Enrolling
Phase 3

Conditions

Functional Constipation
Pelvic Floor Prolapse
Rectocele

Treatments

Procedure: Tibial neuromodulation
Behavioral: Diet modification
Procedure: Biofeedback therapy
Behavioral: Pelvic floor muscles training

Study type

Interventional

Funder types

Other

Identifiers

NCT04547816
DGH-SSCC1

Details and patient eligibility

About

This study is planned to evaluate the efficacy of complex conservative treatment (including tibial neuromodulation, biofeedback therapy, special pelvic floor training and diet modification) in women with pelvic organ prolapse

Full description

Pelvic organ prolapse is a condition with impaired anatomic structure, which may result in defecatory disorders and usually considered as an indication for surgery. However, operation is not always possible. Existing data suggest that functional component may also be possible, despite on the anatomic impairment. The aim of the study is to evaluate the effect of complex conservative treatment of functional defecatory disorders in patients with mild to moderate grade of pelvic organ prolapse

Enrollment

100 estimated patients

Sex

Female

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Willingness to participate (signed informed consent form)
  • Females with rectocele I-II grade or rectocele I-II grade and internal rectal invagination and functional defecatory disorders (per Rome IV guidelines) confirmed on the basis of complex examination including high-resolution anorectal manometry

Exclusion criteria

  • rectocele III grade;
  • internal genitals prolapse;
  • history of abdominal or pelvic surgery that may impact bowel motility (excluding non-complicated appendectomy or laparoscopic cholecystectomy);
  • gynecological surgery that may influence sensory or reservoir function of rectum;
  • history of major cardiovascular events, or presence of current conditions that in case of participation of the patient in the study may put her at risk of exacerbation or complication;
  • start of any new concomitant medication with mechanisms of action that influence rectal motility, sensory function, muscle tone and/or contractility
  • inability to understand and/or follow the instructions to perform all the procedures required per protocol
  • general condition of the patient that make her ineligible by the discretion of the investigator

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 3 patient groups

biofeedback and tibial neuromodulation (BFB+TNM)
Experimental group
Treatment:
Procedure: Biofeedback therapy
Procedure: Tibial neuromodulation
BFB+TNM + pelvic floor muscles training (PFMT)
Experimental group
Treatment:
Behavioral: Pelvic floor muscles training
Procedure: Biofeedback therapy
Procedure: Tibial neuromodulation
BFB+TNM+PFMT+diet modification
Experimental group
Treatment:
Behavioral: Pelvic floor muscles training
Procedure: Biofeedback therapy
Behavioral: Diet modification
Procedure: Tibial neuromodulation

Trial contacts and locations

2

Loading...

Central trial contact

Sergey Morozov, MD, PhD; Oksana Fomenko, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems